Revision history of "Test OF TOLERANCE, SECURITY AND TOXICITY OF INNYECTABLE SOLUTION Intravitrea LISINE salicylate ACETIL VIEW for the treatment of diabetic retinopathy (Patent PCT/ES2016/070396)." (Q3179251)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 00:1300:13, 9 October 2024DG Regio talk contribs 76,707 bytes −2 Changed label, description and/or aliases in pt
  • curprev 00:1300:13, 9 October 2024DG Regio talk contribs 76,709 bytes +43 Set a claim value: summary (P836): A retinopatia diabética é uma das principais causas de cegueira irreversível no mundo, cujo tratamento atual é limitado aos estágios avançados da doença e baseia-se na coagulação a laser da retina em caso de isquemia ou terapia antiangiogénica intravítrea ou esteroide em caso de edema macular. Nenhum destes tratamentos é utilizado em fases menos avançadas para parar a progressão, nem em muitos casos produzir uma melhoria completa, definitiva e estáv...

7 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 04:4904:49, 18 August 2022DG Regio talk contribs 75,393 bytes +51,799 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 19:0219:02, 12 October 2021DG Regio talk contribs 12,754 bytes +236 Changed label, description and/or aliases in en: translated_label
  • curprev 19:0219:02, 12 October 2021DG Regio talk contribs 12,518 bytes +2,263 Created claim: summary (P836): Diabetic retinopathy is one of the main causes of irreversible blindness in the world whose current treatment is limited to the advanced stages of the disease and is based on laser coagulation of the retina in case of ischemia or intravitreal antiangiogenic or steroid therapy in case of macular edema. None of these treatments are used in less advanced phases to stop progression, nor in many cases produce a complete, definitive and stable improve...

10 October 2021

9 October 2021

8 October 2021